Pneumonia News and Research

Latest Pneumonia News and Research

Diabetes patients with poor blood sugar control face highest risk of serious infections

A new study has shown that diabetes patients with the poorest control of their blood sugars face the highest risks of hospitalization and death due to infections.

26 Sep 2018

Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases

Burning wood or coal to cook food is associated with increased risk of hospitalization or dying from respiratory diseases, according to new research conducted in China and published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

25 Sep 2018

Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’

Genomic "islands" that evolved from viruses can be converted into "drones" that disable Staphylococcus aureus, bacteria that are often resistant to antibiotics and pose a threat to safe hospital care, a new study finds.

25 Sep 2018

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.

24 Sep 2018

CSU chemists may help in making extracorporeal life support devices more effective

Smoke inhalation, pneumonia, and combat-related trauma are just a few causes of acute respiratory distress syndrome - a condition where the lungs fill with fluid, and is too often fatal.

24 Sep 2018

October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I

JUST as the cataclysmic conflict of the Great War was in its death throes, a new killer emerged that would, on a global scale, be even more lethal - the Spanish Flu pandemic, which was at its most virulent in October and November 1918.

24 Sep 2018

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.

24 Sep 2018

$CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL$

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.

21 Sep 2018

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.

21 Sep 2018

Study highlights need to remain vigilant in maintaining key infection control processes

Healthcare-associated infections can be reduced by up to 55 percent by systematically implementing evidence-based infection prevention and control strategies, according to a review of 144 studies published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

21 Sep 2018

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pfizer Inc. announced today that its 20-Valent Pneumococcal Conjugate Vaccine candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older. Pfizer expects to start Phase 3 trials in a few months.

20 Sep 2018

Study: Infants using popular anti-reflux medicines are not at increased risk of lung infections

New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies.

19 Sep 2018

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

AmpliPhi Biosciences Corporation, a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company has received positive feedback, via written response, from the U.S. Food and Drug Administration regarding its development plans for AB-PA01, without the need for a Type B Pre-IND meeting.

19 Sep 2018

Experts to present research on prevention, management of dysphagia at international conference

Over 800 delegates from 46 countries will attend the 8th annual European Society for Swallowing Disorders Congress taking place in Dublin next week to hear about new developments in swallowing disorder research.

19 Sep 2018

Study finds higher readmission rates in for-profit hospitals

Patients who receive care in a for-profit hospital are more likely to be readmitted than those who receive care in nonprofit or public hospitals, according to a new study published by University of Illinois at Chicago researchers.

19 Sep 2018

Easy and rapid test for viral infections can cut antibiotic use, hospitalizations

A quick and easy test for viral infections can reduce unnecessary antibiotic use and hospital admissions, according to new research presented to the European Respiratory Society International Congress today.

17 Sep 2018

New technology rapidly assesses antibiotics by using bacteria in bear saliva

If you're looking into the mouth of a brown bear, one of the world's top predators, your chances of survival probably aren't good. But a team of Rutgers and other scientists has discovered a technology that rapidly assesses potentially lifesaving antibiotics by using bacteria in saliva from an East Siberian brown bear.

14 Sep 2018

Researchers identify mechanism that could make pathogens more susceptible to antibiotics

Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant bacteria, a growing global threat as menacing as drug-resistant microbes.

14 Sep 2018

Enabling Patient Care in the Community Through Technology

An interview with Diane Hargrove and Sophie Lindvold at the NHS Health and Care Expo 2018 about how the technologies offered by BES Healthcare can be used to safely discharge patients from acute care and monitor their health status in the community.

From BES Healthcare Ltd 11 Sep 2018

Telehealth videoconferencing promotes antibiotic stewardship efforts in rural facilities

A pilot project at two rural VA medical centers demonstrated that telehealth videoconferencing promoted antibiotic stewardship efforts by linking remote facilities to infectious diseases-trained professionals, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

6 Sep 2018

Pneumonia News and Research

Latest Pneumonia News and Research

Diabetes patients with poor blood sugar control face highest risk of serious infections

Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases

Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

CSU chemists may help in making extracorporeal life support devices more effective

October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

Study highlights need to remain vigilant in maintaining key infection control processes

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Study: Infants using popular anti-reflux medicines are not at increased risk of lung infections

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

Experts to present research on prevention, management of dysphagia at international conference

Study finds higher readmission rates in for-profit hospitals

Easy and rapid test for viral infections can cut antibiotic use, hospitalizations

New technology rapidly assesses antibiotics by using bacteria in bear saliva

Researchers identify mechanism that could make pathogens more susceptible to antibiotics

Enabling Patient Care in the Community Through Technology

Telehealth videoconferencing promotes antibiotic stewardship efforts in rural facilities

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Pneumonia News and Research

Latest Pneumonia News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in